Related Experiment Video
Updated: Jun 29, 2026
04:53
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Stratified experiments reexamined with emphasis on multicenter trials.
Jitendra Ganju1, Devan V Mehrotra
1Chiron Corporation, Emeryville, CA 94608, USA. jitendra_ganju@chiron.com
Controlled Clinical Trials
|April 12, 2003
Summary
Standard analyses in stratified experiments with random stratum sizes can lead to biased results. This study introduces a new analysis method accounting for random stratum sizes, improving inference and estimation in clinical trials.
Area of Science:
- Statistics
- Clinical Trials
- Biostatistics
Background:
- Many stratified experiments, such as multicenter clinical trials, involve fixed total sample sizes but variable sample sizes per stratum.
- Standard statistical analyses often overlook the random nature of these stratum sizes, potentially leading to inaccurate conclusions.
Purpose of the Study:
- To identify biases in standard statistical analyses of stratified experiments with random stratum sizes.
- To propose and validate a novel analysis method that explicitly accounts for random stratum sizes.
Main Methods:
- The study analyzes the impact of random stratum sizes on both type II (unequal weighting) and type III (equal weighting) analyses.
- A new analytical approach is developed to address the randomness of stratum sizes.
- Simulations are used to assess the validity and performance of the proposed method.
Main Results:
- Standard analyses were found to produce biased inference and estimation when stratum sizes are random.
- The proposed method demonstrates improved accuracy and reliability in simulations.
- Reanalysis of published clinical trial data confirms the practical benefits of the new approach.
Conclusions:
- Researchers must account for random stratum sizes in stratified experiments to ensure valid statistical inference.
- The proposed analysis method offers a more robust approach for continuous data in multicenter clinical trials.
- This work has significant implications for the design and analysis of complex clinical studies.
Related Concept Videos
01:13Randomized Experiments
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Simple randomization
Simple...
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:16Crossover Experiments
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
01:11Bioavailability Study Design: Single Versus Multiple Dose Studies
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
01:20Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...
01:15Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...